youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
GUD:TSE
Knight Therapeutics Inc
CA$11.32
arrow_upward
+0.44%(+0.050) 1D
Nov 2, 4:00:00 PM GMT-5 · CAD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GUD...
Open
CA$11.34
High
CA$11.44
Low
CA$11.26
Mkt. cap
1.11B
Avg. vol.
65.52K
Volume
0.00
P/E ratio
75.48
52-wk high
CA$11.83
52-wk low
CA$5.66
EPS
CA$0.15
Beta
-0.07
Shares outstanding
98.23M
No. of employees
830
Open
CA$11.34
High
CA$11.44
Low
CA$11.26
Mkt. cap
1.11B
Avg. vol.
65.52K
Volume
0.00
P/E ratio
75.48
52-wk high
CA$11.83
52-wk low
CA$5.66
EPS
CA$0.15
Beta
-0.07
Shares outstanding
98.23M
No. of employees
830
News stories
From web sources and news partners
MarketWatch
·
18 minutes ago
This signal from the corporate bond market has historically preceded big drawdowns for the S&P 500
BigGo Finance
·
44 minutes ago
NYSE Taps Broadridge to Run Onchain Voting for Its Tokenized Stock Venue
Investing.com
·
29 minutes ago
Nasdaq sank -5.3%, but these AI strategies surged up to +9.3% in October
The Motley Fool
·
49 minutes ago
The Company Behind the New York Stock Exchange Is Now Building on Hyperliquid. Here's What It Means for Investors.
Profile
Knight Therapeutics Inc. is a Canadian public specialty pharmaceutical company based in Montreal, Quebec that focuses on acquiring or in-licensing innovative pharmaceutical products for the Canadian and select international markets. It is listed on the Toronto Stock Exchange, with a market capitalization of $1.02 billion as of August 2019. Wikipedia
About Knight Therapeutics Inc
CEO-
Employees830
Founded2014
HeadquartersMontreal, Quebec, Canada
SectorPharmaceutical industry
Websiteknighttx.com